Several states have passed tort reform laws, including Texas. It hasn't made any difference.

The big pharma players spend more on marketing than R&D. The smaller players like Mylan specifically try to find niche drugs so they can buy the rights and jack the prices. It's pure rent-extraction and a drain on our healthcare system and economy.